1. Home
  2. VYGR vs ORN Comparison

VYGR vs ORN Comparison

Compare VYGR & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • ORN
  • Stock Information
  • Founded
  • VYGR 2013
  • ORN 1994
  • Country
  • VYGR United States
  • ORN United States
  • Employees
  • VYGR N/A
  • ORN N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • ORN Military/Government/Technical
  • Sector
  • VYGR Health Care
  • ORN Industrials
  • Exchange
  • VYGR Nasdaq
  • ORN Nasdaq
  • Market Cap
  • VYGR 386.1M
  • ORN 316.7M
  • IPO Year
  • VYGR 2015
  • ORN 2007
  • Fundamental
  • Price
  • VYGR $5.43
  • ORN $8.71
  • Analyst Decision
  • VYGR Strong Buy
  • ORN Strong Buy
  • Analyst Count
  • VYGR 8
  • ORN 2
  • Target Price
  • VYGR $17.00
  • ORN $13.25
  • AVG Volume (30 Days)
  • VYGR 583.2K
  • ORN 537.0K
  • Earning Date
  • VYGR 11-12-2024
  • ORN 10-30-2024
  • Dividend Yield
  • VYGR N/A
  • ORN N/A
  • EPS Growth
  • VYGR N/A
  • ORN N/A
  • EPS
  • VYGR 0.47
  • ORN N/A
  • Revenue
  • VYGR $163,784,000.00
  • ORN $781,108,000.00
  • Revenue This Year
  • VYGR N/A
  • ORN $20.86
  • Revenue Next Year
  • VYGR N/A
  • ORN $1.98
  • P/E Ratio
  • VYGR $11.65
  • ORN N/A
  • Revenue Growth
  • VYGR 3.40
  • ORN 10.58
  • 52 Week Low
  • VYGR $5.19
  • ORN $4.09
  • 52 Week High
  • VYGR $11.72
  • ORN $12.12
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 34.18
  • ORN 72.22
  • Support Level
  • VYGR $5.19
  • ORN $7.51
  • Resistance Level
  • VYGR $5.59
  • ORN $8.35
  • Average True Range (ATR)
  • VYGR 0.41
  • ORN 0.53
  • MACD
  • VYGR -0.19
  • ORN 0.14
  • Stochastic Oscillator
  • VYGR 10.71
  • ORN 95.75

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar, and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: